Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Substrate binding mode and catalytic mechanism of human heparan sulfate d-glucuronyl C5 epimerase.

Debarnot C, Monneau YR, Roig-Zamboni V, Delauzun V, Le Narvor C, Richard E, Hénault J, Goulet A, Fadel F, Vivès RR, Priem B, Bonnaffé D, Lortat-Jacob H, Bourne Y.

Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):6760-6765. doi: 10.1073/pnas.1818333116. Epub 2019 Mar 14.

PMID:
30872481
2.

Expression and purification of recombinant extracellular sulfatase HSulf-2 allows deciphering of enzyme sub-domain coordinated role for the binding and 6-O-desulfation of heparan sulfate.

Seffouh A, El Masri R, Makshakova O, Gout E, Hassoun ZEO, Andrieu JP, Lortat-Jacob H, Vivès RR.

Cell Mol Life Sci. 2019 May;76(9):1807-1819. doi: 10.1007/s00018-019-03027-2. Epub 2019 Feb 20.

PMID:
30788513
3.

A proliferation-inducing ligand-mediated anti-inflammatory response of astrocytes in multiple sclerosis.

Baert L, Benkhoucha M, Popa N, Ahmed MC, Manfroi B, Boutonnat J, Sturm N, Raguenez G, Tessier M, Casez O, Marignier R, Ahmadi M, Broisat A, Ghezzi C, Rivat C, Sonrier C, Hahne M, Baeten D, Vives RR, Lortat-Jacob H, Marche PN, Schneider P, Lassmann HP, Boucraut J, Lalive PH, Huard B.

Ann Neurol. 2019 Mar;85(3):406-420. doi: 10.1002/ana.25415. Epub 2019 Feb 4.

PMID:
30635946
4.

CCR5 structural plasticity shapes HIV-1 phenotypic properties.

Colin P, Zhou Z, Staropoli I, Garcia-Perez J, Gasser R, Armani-Tourret M, Benureau Y, Gonzalez N, Jin J, Connell BJ, Raymond S, Delobel P, Izopet J, Lortat-Jacob H, Alcami J, Arenzana-Seisdedos F, Brelot A, Lagane B.

PLoS Pathog. 2018 Dec 6;14(12):e1007432. doi: 10.1371/journal.ppat.1007432. eCollection 2018 Dec.

5.

Editorial overview: Carbohydrates: Ménage à trois with glycosaminoglycans-a serious rendezvous, not a gag!

Richter RP, Lortat-Jacob H.

Curr Opin Struct Biol. 2018 Jun;50:iv-vi. doi: 10.1016/j.sbi.2018.07.004. No abstract available.

6.

Genetic and enzymatic characterization of 3-O-sulfotransferase SNPs associated with Plasmodium falciparum parasitaemia.

Nguyen NT, Vivès RR, Torres M, Delauzun V, Saesen E, Roig-Zamboni V, Lortat-Jacob H, Rihet P, Bourne Y.

Glycobiology. 2018 Jul 1;28(7):534-541. doi: 10.1093/glycob/cwy038.

7.

Solution structure of CXCL13 and heparan sulfate binding show that GAG binding site and cellular signalling rely on distinct domains.

Monneau YR, Luo L, Sankaranarayanan NV, Nagarajan B, Vivès RR, Baleux F, Desai UR, Arenzana-Seidedos F, Lortat-Jacob H.

Open Biol. 2017 Oct;7(10). pii: 170133. doi: 10.1098/rsob.170133.

8.

A jasmonic acid derivative improves skin healing and induces changes in proteoglycan expression and glycosaminoglycan structure.

Henriet E, Jäger S, Tran C, Bastien P, Michelet JF, Minondo AM, Formanek F, Dalko-Csiba M, Lortat-Jacob H, Breton L, Vivès RR.

Biochim Biophys Acta Gen Subj. 2017 Sep;1861(9):2250-2260. doi: 10.1016/j.bbagen.2017.06.006. Epub 2017 Jun 8.

PMID:
28602514
9.

A Versatile Electronic Tongue Based on Surface Plasmon Resonance Imaging and Cross-Reactive Sensor Arrays-A Mini-Review.

Garçon LA, Genua M, Hou Y, Buhot A, Calemczuk R, Livache T, Billon M, Le Narvor C, Bonnaffé D, Lortat-Jacob H, Hou Y.

Sensors (Basel). 2017 May 6;17(5). pii: E1046. doi: 10.3390/s17051046. Review.

10.

Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4.

Collins PJ, McCully ML, Martínez-Muñoz L, Santiago C, Wheeldon J, Caucheteux S, Thelen S, Cecchinato V, Laufer JM, Purvanov V, Monneau YR, Lortat-Jacob H, Legler DF, Uguccioni M, Thelen M, Piguet V, Mellado M, Moser B.

FASEB J. 2017 Jul;31(7):3084-3097. doi: 10.1096/fj.201700013R. Epub 2017 Mar 30.

11.

CCL2 nitration is a negative regulator of chemokine-mediated inflammation.

Barker CE, Thompson S, O'Boyle G, Lortat-Jacob H, Sheerin NS, Ali S, Kirby JA.

Sci Rep. 2017 Mar 14;7:44384. doi: 10.1038/srep44384.

12.

Biomaterial-enabled delivery of SDF-1α at the ventral side of breast cancer cells reveals a crosstalk between cell receptors to promote the invasive phenotype.

Liu XQ, Fourel L, Dalonneau F, Sadir R, Leal S, Lortat-Jacob H, Weidenhaupt M, Albiges-Rizo C, Picart C.

Biomaterials. 2017 May;127:61-74. doi: 10.1016/j.biomaterials.2017.02.035. Epub 2017 Feb 27.

13.

Binding of the chemokine CXCL12α to its natural extracellular matrix ligand heparan sulfate enables myoblast adhesion and facilitates cell motility.

Thakar D, Dalonneau F, Migliorini E, Lortat-Jacob H, Boturyn D, Albiges-Rizo C, Coche-Guerente L, Picart C, Richter RP.

Biomaterials. 2017 Apr;123:24-38. doi: 10.1016/j.biomaterials.2017.01.022. Epub 2017 Jan 19.

14.

Lack of ADCC Breadth of Human Nonneutralizing Anti-HIV-1 Antibodies.

Bruel T, Guivel-Benhassine F, Lorin V, Lortat-Jacob H, Baleux F, Bourdic K, Noël N, Lambotte O, Mouquet H, Schwartz O.

J Virol. 2017 Mar 29;91(8). pii: e02440-16. doi: 10.1128/JVI.02440-16. Print 2017 Apr 15.

15.

Chondroitin sulfates and their binding molecules in the central nervous system.

Djerbal L, Lortat-Jacob H, Kwok J.

Glycoconj J. 2017 Jun;34(3):363-376. doi: 10.1007/s10719-017-9761-z. Epub 2017 Jan 18. Review.

16.

The "in and out" of glucosamine 6-O-sulfation: the 6th sense of heparan sulfate.

El Masri R, Seffouh A, Lortat-Jacob H, Vivès RR.

Glycoconj J. 2017 Jun;34(3):285-298. doi: 10.1007/s10719-016-9736-5. Epub 2016 Nov 3. Review.

PMID:
27812771
17.

Heparan sulfate differentially controls CXCL12α- and CXCL12γ-mediated cell migration through differential presentation to their receptor CXCR4.

Connell BJ, Sadir R, Baleux F, Laguri C, Kleman JP, Luo L, Arenzana-Seisdedos F, Lortat-Jacob H.

Sci Signal. 2016 Nov 1;9(452):ra107.

PMID:
27803285
18.

A Cinnamon-Derived Procyanidin Compound Displays Anti-HIV-1 Activity by Blocking Heparan Sulfate- and Co-Receptor- Binding Sites on gp120 and Reverses T Cell Exhaustion via Impeding Tim-3 and PD-1 Upregulation.

Connell BJ, Chang SY, Prakash E, Yousfi R, Mohan V, Posch W, Wilflingseder D, Moog C, Kodama EN, Clayette P, Lortat-Jacob H.

PLoS One. 2016 Oct 27;11(10):e0165386. doi: 10.1371/journal.pone.0165386. eCollection 2016.

19.

CD4-mimetic sulfopeptide conjugates display sub-nanomolar anti-HIV-1 activity and protect macaques against a SHIV162P3 vaginal challenge.

Ariën KK, Baleux F, Desjardins D, Porrot F, Coïc YM, Michiels J, Bouchemal K, Bonnaffé D, Bruel T, Schwartz O, Le Grand R, Vanham G, Dereuddre-Bosquet N, Lortat-Jacob H.

Sci Rep. 2016 Oct 10;6:34829. doi: 10.1038/srep34829.

20.

Interplay between transglutaminases and heparan sulphate in progressive renal scarring.

Burhan I, Furini G, Lortat-Jacob H, Atobatele AG, Scarpellini A, Schroeder N, Atkinson J, Maamra M, Nutter FH, Watson P, Vinciguerra M, Johnson TS, Verderio EA.

Sci Rep. 2016 Oct 3;6:31343. doi: 10.1038/srep31343.

21.

The sweet spot: how GAGs help chemokines guide migrating cells.

Monneau Y, Arenzana-Seisdedos F, Lortat-Jacob H.

J Leukoc Biol. 2016 Jun;99(6):935-53. doi: 10.1189/jlb.3MR0915-440R. Epub 2015 Dec 23. Review.

PMID:
26701132
22.

Hexagonal-shaped chondroitin sulfate self-assemblies have exalted anti-HSV-2 activity.

Galus A, Mallet JM, Lembo D, Cagno V, Djabourov M, Lortat-Jacob H, Bouchemal K.

Carbohydr Polym. 2016 Jan 20;136:113-20. doi: 10.1016/j.carbpol.2015.08.054. Epub 2015 Aug 20.

PMID:
26572336
23.

Cytokines and growth factors cross-link heparan sulfate.

Migliorini E, Thakar D, Kühnle J, Sadir R, Dyer DP, Li Y, Sun C, Volkman BF, Handel TM, Coche-Guerente L, Fernig DG, Lortat-Jacob H, Richter RP.

Open Biol. 2015 Aug;5(8). pii: 150046. doi: 10.1098/rsob.150046.

24.

The interaction of heparan sulfate proteoglycans with endothelial transglutaminase-2 limits VEGF165-induced angiogenesis.

Beckouche N, Bignon M, Lelarge V, Mathivet T, Pichol-Thievend C, Berndt S, Hardouin J, Garand M, Ardidie-Robouant C, Barret A, Melino G, Lortat-Jacob H, Muller L, Monnot C, Germain S.

Sci Signal. 2015 Jul 14;8(385):ra70. doi: 10.1126/scisignal.aaa0963.

PMID:
26175493
25.

A single-residue change in the HIV-1 V3 loop associated with maraviroc resistance impairs CCR5 binding affinity while increasing replicative capacity.

Garcia-Perez J, Staropoli I, Azoulay S, Heinrich JT, Cascajero A, Colin P, Lortat-Jacob H, Arenzana-Seisdedos F, Alcami J, Kellenberger E, Lagane B.

Retrovirology. 2015 Jun 18;12:50. doi: 10.1186/s12977-015-0177-1.

26.

Hydration water mobility is enhanced around tau amyloid fibers.

Fichou Y, Schirò G, Gallat FX, Laguri C, Moulin M, Combet J, Zamponi M, Härtlein M, Picart C, Mossou E, Lortat-Jacob H, Colletier JP, Tobias DJ, Weik M.

Proc Natl Acad Sci U S A. 2015 May 19;112(20):6365-70. doi: 10.1073/pnas.1422824112. Epub 2015 Apr 27.

27.

Acidosis increases MHC class II-restricted presentation of a protein endowed with a pH-dependent heparan sulfate-binding ability.

Knittel D, Savatier A, Upert G, Lortat-Jacob H, Léonetti M.

J Immunol. 2015 Apr 15;194(8):3601-11. doi: 10.4049/jimmunol.1401902. Epub 2015 Mar 9.

28.

C5-epimerase and 2-O-sulfotransferase associate in vitro to generate contiguous epimerized and 2-O-sulfated heparan sulfate domains.

Préchoux A, Halimi C, Simorre JP, Lortat-Jacob H, Laguri C.

ACS Chem Biol. 2015 Apr 17;10(4):1064-71. doi: 10.1021/cb501037a. Epub 2015 Jan 28.

PMID:
25594747
29.

On-line capillary isoelectric focusing hyphenated to native electrospray ionization mass spectrometry for the characterization of interferon-γ and variants.

Przybylski C, Mokaddem M, Prull-Janssen M, Saesen E, Lortat-Jacob H, Gonnet F, Varenne A, Daniel R.

Analyst. 2015 Jan 21;140(2):543-50. doi: 10.1039/c4an01305k.

PMID:
25408953
30.

A quartz crystal microbalance method to study the terminal functionalization of glycosaminoglycans.

Thakar D, Migliorini E, Coche-Guerente L, Sadir R, Lortat-Jacob H, Boturyn D, Renaudet O, Labbe P, Richter RP.

Chem Commun (Camb). 2014 Dec 14;50(96):15148-51. doi: 10.1039/c4cc06905f.

PMID:
25338834
31.

Profiling sulfation/epimerization pattern of full-length heparan sulfate by NMR following cell culture 13C-glucose metabolic labeling.

Pegeot M, Sadir R, Eriksson I, Kjellen L, Simorre JP, Gans P, Lortat-Jacob H.

Glycobiology. 2015 Feb;25(2):151-6. doi: 10.1093/glycob/cwu114. Epub 2014 Oct 21.

PMID:
25335974
32.

Electronic tongue generating continuous recognition patterns for protein analysis.

Hou Y, Genua M, Garçon LA, Buhot A, Calemczuk R, Bonnaffé D, Lortat-Jacob H, Livache T.

J Vis Exp. 2014 Sep 16;(91):51901. doi: 10.3791/51901.

33.

Heparan sulfate saccharides modify focal adhesions: implication in mucopolysaccharidosis neuropathophysiology.

Bruyère J, Roy E, Ausseil J, Lemonnier T, Teyre G, Bohl D, Etienne-Manneville S, Lortat-Jacob H, Heard JM, Vitry S.

J Mol Biol. 2015 Feb 27;427(4):775-791. doi: 10.1016/j.jmb.2014.09.012. Epub 2014 Sep 28.

PMID:
25268803
34.

Well-defined biomimetic surfaces to characterize glycosaminoglycan-mediated interactions on the molecular, supramolecular and cellular levels.

Migliorini E, Thakar D, Sadir R, Pleiner T, Baleux F, Lortat-Jacob H, Coche-Guerente L, Richter RP.

Biomaterials. 2014 Oct;35(32):8903-15. doi: 10.1016/j.biomaterials.2014.07.017. Epub 2014 Aug 1.

PMID:
25088726
35.

Importance of the polarity of the glycosaminoglycan chain on the interaction with FGF-1.

Muñoz-García JC, García-Jiménez MJ, Carrero P, Canales A, Jiménez-Barbero J, Martín-Lomas M, Imberty A, de Paz JL, Angulo J, Lortat-Jacob H, Nieto PM.

Glycobiology. 2014 Nov;24(11):1004-9. doi: 10.1093/glycob/cwu071. Epub 2014 Jul 11.

PMID:
25015527
36.

The effect of delivering the chemokine SDF-1α in a matrix-bound manner on myogenesis.

Dalonneau F, Liu XQ, Sadir R, Almodovar J, Mertani HC, Bruckert F, Albiges-Rizo C, Weidenhaupt M, Lortat-Jacob H, Picart C.

Biomaterials. 2014 May;35(15):4525-4535. doi: 10.1016/j.biomaterials.2014.02.008. Epub 2014 Mar 5.

37.

Post-Synthetic Regulation of HS Structure: The Yin and Yang of the Sulfs in Cancer.

Vivès RR, Seffouh A, Lortat-Jacob H.

Front Oncol. 2014 Jan 14;3:331. doi: 10.3389/fonc.2013.00331. eCollection 2014 Jan 14. Review.

38.

Human immunodeficiency virus and heparan sulfate: from attachment to entry inhibition.

Connell BJ, Lortat-Jacob H.

Front Immunol. 2013 Nov 20;4:385. doi: 10.3389/fimmu.2013.00385. Review.

39.

The disulfide bond between cysteine 10 and cysteine 34 is required for CCL18 activity.

Legendre B, Tokarski C, Chang Y, De Freitas Caires N, Lortat-Jacob H, Nadaï PD, Rolando C, Duez C, Tsicopoulos A, Lassalle P.

Cytokine. 2013 Oct;64(1):463-70. doi: 10.1016/j.cyto.2013.04.028. Epub 2013 Jun 3.

PMID:
23742785
40.

Insights into the mechanism by which interferon-γ basic amino acid clusters mediate protein binding to heparan sulfate.

Saesen E, Sarrazin S, Laguri C, Sadir R, Maurin D, Thomas A, Imberty A, Lortat-Jacob H.

J Am Chem Soc. 2013 Jun 26;135(25):9384-90. doi: 10.1021/ja4000867. Epub 2013 Jun 13.

PMID:
23734709
41.

HSulf sulfatases catalyze processive and oriented 6-O-desulfation of heparan sulfate that differentially regulates fibroblast growth factor activity.

Seffouh A, Milz F, Przybylski C, Laguri C, Oosterhof A, Bourcier S, Sadir R, Dutkowski E, Daniel R, van Kuppevelt TH, Dierks T, Lortat-Jacob H, Vivès RR.

FASEB J. 2013 Jun;27(6):2431-9. doi: 10.1096/fj.12-226373. Epub 2013 Mar 1.

PMID:
23457216
42.

Inflammatory chemokines direct and restrict leukocyte migration within live tissues as glycan-bound gradients.

Sarris M, Masson JB, Maurin D, Van der Aa LM, Boudinot P, Lortat-Jacob H, Herbomel P.

Curr Biol. 2012 Dec 18;22(24):2375-82. doi: 10.1016/j.cub.2012.11.018. Epub 2012 Dec 6.

43.

Toward libraries of biotinylated chondroitin sulfate analogues: from synthesis to in vivo studies.

Despras G, Bernard C, Perrot A, Cattiaux L, Prochiantz A, Lortat-Jacob H, Mallet JM.

Chemistry. 2013 Jan 7;19(2):531-40. doi: 10.1002/chem.201202173. Epub 2012 Nov 14.

PMID:
23154924
44.

A New C-Xyloside induces modifications of GAG expression, structure and functional properties.

Vassal-Stermann E, Duranton A, Black AF, Azadiguian G, Demaude J, Lortat-Jacob H, Breton L, Vivès RR.

PLoS One. 2012;7(10):e47933. doi: 10.1371/journal.pone.0047933. Epub 2012 Oct 26.

45.

Homeostatic and tissue reparation defaults in mice carrying selective genetic invalidation of CXCL12/proteoglycan interactions.

Rueda P, Richart A, Récalde A, Gasse P, Vilar J, Guérin C, Lortat-Jacob H, Vieira P, Baleux F, Chretien F, Arenzana-Seisdedos F, Silvestre JS.

Circulation. 2012 Oct 9;126(15):1882-95. doi: 10.1161/CIRCULATIONAHA.112.113290. Epub 2012 Oct 3.

46.

Continuous evolution profiles for electronic-tongue-based analysis.

Hou Y, Genua M, Tada Batista D, Calemczuk R, Buhot A, Fornarelli P, Koubachi J, Bonnaffé D, Saesen E, Laguri C, Lortat-Jacob H, Livache T.

Angew Chem Int Ed Engl. 2012 Oct 8;51(41):10394-8. doi: 10.1002/anie.201205346. Epub 2012 Sep 11. No abstract available.

PMID:
22968809
47.

Factor h and properdin recognize different epitopes on renal tubular epithelial heparan sulfate.

Zaferani A, Vivès RR, van der Pol P, Navis GJ, Daha MR, van Kooten C, Lortat-Jacob H, Seelen MA, van den Born J.

J Biol Chem. 2012 Sep 7;287(37):31471-81. doi: 10.1074/jbc.M112.380386. Epub 2012 Jul 19.

48.

Transglutaminase-2 interaction with heparin: identification of a heparin binding site that regulates cell adhesion to fibronectin-transglutaminase-2 matrix.

Lortat-Jacob H, Burhan I, Scarpellini A, Thomas A, Imberty A, Vivès RR, Johnson T, Gutierrez A, Verderio EA.

J Biol Chem. 2012 May 25;287(22):18005-17. doi: 10.1074/jbc.M111.337089. Epub 2012 Mar 22.

49.

Cell surface proteoglycans syndecan-1 and -4 bind overlapping but distinct sites in laminin α3 LG45 protein domain.

Carulli S, Beck K, Dayan G, Boulesteix S, Lortat-Jacob H, Rousselle P.

J Biol Chem. 2012 Apr 6;287(15):12204-16. doi: 10.1074/jbc.M111.300061. Epub 2012 Feb 20.

50.

A synthetic heparan sulfate-mimetic peptide conjugated to a mini CD4 displays very high anti- HIV-1 activity independently of coreceptor usage.

Connell BJ, Baleux F, Coic YM, Clayette P, Bonnaffé D, Lortat-Jacob H.

Chem Biol. 2012 Jan 27;19(1):131-9. doi: 10.1016/j.chembiol.2011.12.009.

Supplemental Content

Loading ...
Support Center